 Clinical
“Randomized, Double-Masked Study of Four Iontophoresis Dose Levels of EGP-437 in Non-Infectious Anterior Segment Uveitis Subjects” “A Non-Invasive Ocular Drug Delivery System that Delivers Substantially Greater Antibiotic Levels than Topical Administration” “Randomized, Double-Masked, Placebo-Controlled Phase II Study of EGP-437 in Dry Eye Patients”
ResearchTrans-scleral Iontophoretic Delivery of Low Molecular Weight Therapeutics. Download Abstract (Word.doc) “Non-invasive Delivery of Biodegradable Drug-containing Nanoparticles by Ocular Iontophoresis” |
| |
 |
 |
 |
 |
 |
 |
 |
 |